OWC Pharmaceutical Research Corp (OWCP):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:OWC Pharmaceutical Research Corp (OWCP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9368
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OWC Pharmaceutical Research Corp (OWC Pharmaceutical), formerly Dynamic Applications Corp, is a drug development company that discovers, develops, and commercializes cannabis-based novel therapeutics products and treatments for several medical conditions. The company offers sublingual soluble tablets and topical cream. Its sublingual soluble tablets provide patients with an alternative to smoking cannabis (marijuana) buds for the treatment and management of pain. OWC Pharmaceutical’s topical cream is used for the treatment of various skin diseases. The company’s products are also used for the treatment of multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder, and migraines. It offers medical cannabis regulatory compliance and patient-care consultancy services. The company operates through its subsidiary in Israel. OWC Pharmaceutical is headquartered in Ramat Gan, Israel.

OWC Pharmaceutical Research Corp (OWCP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OWC Pharmaceutical Research Corp, Medical Devices Deals, 2012 to YTD 2018 9
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Kodiak Capital Group to Invest USD0.7 Million in OWC Pharma 11
Partnerships 12
OWC Pharmaceutical Research Entered into a License Agreement with Emilia Cosmetics 12
One World Cannabis Enters into Agreement with G.C. Group 13
One World Cannabis Signs Collaboration Agreement with Sheba Academic Medical Center 14
OWC Pharmaceutical Research Enters into Agreement with Sheba Academic Medical Center 15
OWC Pharmaceutical Research Enters into Agreement with GUMI Tel Aviv 16
Licensing Agreements 17
OWC Pharmaceutical Enters into License Agreement with Sheba Academic Medical for Fibromyalgia 17
OWC Pharmaceutical Enters into License Agreement with Sheba Academic Medical for Psoriasis 18
Equity Offering 19
OWC Pharma Raises USD5 Million in Private Placement of Shares 19
OWC Pharma to Raise USD0.3 Million in Private Placement of Shares 20
OWC Pharma Raises USD0.02 Million in Priavte Placement of Shares 21
OWC Pharmaceutical Raises USD0.65 Million in Priavte Placement of Shares 22
OWC Pharmaceutical Research Raises USD1.1 Million in Private Placement of Units 23
OWC Pharmaceutical Research Raises USD0.9 Million in Priavte Placement of Units 24
OWC Pharmaceutical Research Corp – Key Competitors 25
OWC Pharmaceutical Research Corp – Key Employees 26
OWC Pharmaceutical Research Corp – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Corporate Communications 28
Feb 20, 2018: OWC Pharmaceutical Research Appoints Dr. Oron Yacoby Zeevi as its Chief Scientific Officer 28
Jul 25, 2017: OWC Pharmaceutical Research Corp Appoints Dr. Stanley Hirsch as its Active Chairman 29
Jan 27, 2017: OWC Pharmaceutical Research Announces the Nominations of Ms. Miriam Sani, MSc Eng., to its Advisory Board 30
Product News 31
Dec 21, 2017: OWC Pharmaceutical Research Announces Update on its Proprietary Medical Cannabis Sublingual Tablet 31
Other Significant Developments 32
Jul 24, 2018: OWC Pharmaceutical Research letter to shareholders 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OWC Pharmaceutical Research Corp, Deals By Therapy Area, 2012 to YTD 2018 8
OWC Pharmaceutical Research Corp, Medical Devices Deals, 2012 to YTD 2018 9
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kodiak Capital Group to Invest USD0.7 Million in OWC Pharma 11
OWC Pharmaceutical Research Entered into a License Agreement with Emilia Cosmetics 12
One World Cannabis Enters into Agreement with G.C. Group 13
One World Cannabis Signs Collaboration Agreement with Sheba Academic Medical Center 14
OWC Pharmaceutical Research Enters into Agreement with Sheba Academic Medical Center 15
OWC Pharmaceutical Research Enters into Agreement with GUMI Tel Aviv 16
OWC Pharmaceutical Enters into License Agreement with Sheba Academic Medical for Fibromyalgia 17
OWC Pharmaceutical Enters into License Agreement with Sheba Academic Medical for Psoriasis 18
OWC Pharma Raises USD5 Million in Private Placement of Shares 19
OWC Pharma to Raise USD0.3 Million in Private Placement of Shares 20
OWC Pharma Raises USD0.02 Million in Priavte Placement of Shares 21
OWC Pharmaceutical Raises USD0.65 Million in Priavte Placement of Shares 22
OWC Pharmaceutical Research Raises USD1.1 Million in Private Placement of Units 23
OWC Pharmaceutical Research Raises USD0.9 Million in Priavte Placement of Units 24
OWC Pharmaceutical Research Corp, Key Competitors 25
OWC Pharmaceutical Research Corp, Key Employees 26
OWC Pharmaceutical Research Corp, Subsidiaries 27

List of Figures
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OWC Pharmaceutical Research Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[OWC Pharmaceutical Research Corp (OWCP):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Time Technoplast Ltd.:戦略・SWOT・企業財務分析
    Time Technoplast Ltd. - Strategy, SWOT and Corporate Finance Report Summary Time Technoplast Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Allscripts Healthcare Solutions Inc (MDRX):企業の財務・戦略的SWOT分析
    Allscripts Healthcare Solutions Inc (MDRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Ambuja Cements Limited:企業の戦略・SWOT・財務分析
    Ambuja Cements Limited - Strategy, SWOT and Corporate Finance Report Summary Ambuja Cements Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Solvay SA (SOLB)-エネルギー分野:企業M&A・提携分析
    Summary Solvay SA (Solvay) is a chemical manufacturing company, which carries out production of specialty polymers, essential chemicals, silica and rare earth systems, consumer chemicals, polyamide and intermediates, vinyls and acetate tow. Its products include chemical products such as barium stron …
  • CaixaBank SA:企業の戦略・SWOT・財務情報
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Kiadis Pharma NV (KDS):企業の財務・戦略的SWOT分析
    Summary Kiadis Pharma NV (Kiadis) is a biopharmaceutical company that develops and markets cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company offers cellular products including ATIR101 and ATIR201 for infusion. Its ATIR101 lowers the risks …
  • Cell C (Pty) Ltd.:企業の戦略・SWOT・財務情報
    Cell C (Pty) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cell C (Pty) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Align Technology, Inc.:戦略・SWOT・企業財務分析
    Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report Summary Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • China National Petroleum Corporation (CNPC):戦略・SWOT・企業財務分析
    China National Petroleum Corporation (CNPC) - Strategy, SWOT and Corporate Finance Report Summary China National Petroleum Corporation (CNPC) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Crinetics Pharmaceuticals Inc (CRNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Crinetics Pharmaceuticals Inc (Crinetics) is a developer of novel therapeutics targeting peptide hormone receptors for the treatment of rare endocrine disorders and endocrine-related cancers. The company’s products include neuropeptides and their receptors, orally-available somatostatin agon …
  • Kirayaka Bank, Ltd.:企業の戦略・SWOT・財務情報
    Kirayaka Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kirayaka Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Rinnai Corp (5947):企業の財務・戦略的SWOT分析
    Rinnai Corp (5947) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Fugro NV (FUR):石油・ガス:M&Aディール及び事業提携情報
    Summary Fugro NV (Fugro) is an integrated provider of geotechnical, survey, subsea and geosciences services. The company specializes in earth and engineering data services, from project preparation through to data acquisition, processing, analysis and interpretation, reporting and consulting. It ass …
  • Tecpetrol S.A.:企業の戦略・SWOT・財務情報
    Tecpetrol S.A. - Strategy, SWOT and Corporate Finance Report Summary Tecpetrol S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Terumo BCT Inc-製薬・医療分野:企業M&A・提携分析
    Summary Terumo BCT Inc (Terumo BCT), a subsidiary of Terumo Corp, provides blood component, therapeutic apheresis, and cellular technologies. The company’s product portfolio include automated blood collection system, information system, data collection system, apheresis system, cell processor, cell …
  • Nedbank Group Ltd (NED):企業の財務・戦略的SWOT分析
    Nedbank Group Ltd (NED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Trustees Australia Ltd:企業の戦略・SWOT・財務分析
    Trustees Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Trustees Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Aselsan Elektronik Sanayi Ve Ticaret A.S.:企業の戦略・SWOT・財務情報
    Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Hexza Corporation Berhad (HEXZA):企業の財務・戦略的SWOT分析
    Hexza Corporation Berhad (HEXZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • BioClin Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioClin Therapeutics Inc (BioClin) is a clinical stage biotechnology company developing protein therapeutics for genetic disorders. Its lead product candidate B-701 is a human monoclonal antibody which targets the activity of FGFR3 (fibroblast growth factor receptor 3) and does not interact …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆